FDA — authorised 17 September 2001
- Application: BLA103951
- Marketing authorisation holder: AMGEN
- Local brand name: ARANESP
- Indication: VIAL — INTRAVENOUS
- Status: approved
🇺🇸 Darbeopoetin in United States
FDA authorised Darbeopoetin on 17 September 2001
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Darbeopoetin approved in United States?
Yes. FDA authorised it on 17 September 2001.
Who is the marketing authorisation holder for Darbeopoetin in United States?
AMGEN holds the US marketing authorisation.